Spok Holdings, Inc.
HealthcareNASDAQ:SPOK · NASDAQ Global Select
+$0.11 today
Vol 0.09M · Avg 0.17M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
10.8%
avg 2.5%
ROIC
9.1%
avg 2.8%
ROA
7.7%
avg 2.1%
Analysis
ROE is currently the strongest return metric at 10.8% versus its period average of 2.5%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Vincent D. Kelly | President, Chief Executive Officer & Director | $1.41M | — | 66 | $167,565.00 | 0.80% |
Michael W. Wallace | CFO & COO | $1.07M | — | 57 | $125,226.00 | 0.60% |
Calvin C. Rice | Chief Financial Officer & Chief Accounting Officer | $612,101.00 | — | 40 | $67,830.00 | 0.32% |
Sharon Woods Keisling | Corporate Secretary & Treasurer | $554,727.00 | — | 57 | $48,264.00 | 0.23% |
James H. Boso | Executive Consultant of Sales and M&A | $536,982.00 | — | 78 | — | — |
Renee Hall | Chief Compliance Officer and Vice President of HR & Administration | — | — | — | — | — |
Timothy E. Tindle | Chief Information Officer & Chief Technology Officer | — | — | — | — | — |
Jonathan Wax | Executive Vice President of Sales | — | — | — | — | — |
Michael Czop | Chief Information Officer & Chief Information Security Officer | — | — | — | $125,226.00 | 0.60% |
Al Galgano | Investor Relations Contact | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
3
$106,819.50
Sells
48
$9.43M
Net Sentiment
$9.33M
Net selling
Most Active
Stein Todd J
34 transactions
1–10 of 51
Analysis
Insiders reported 3 buys worth $106,819.50 and 48 sells worth $9.43M over the last 12 months. That adds up to net selling of $9.33M. Stein Todd J was the most active insider with 34 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +40.7% | -15.1% (11yr)1 analysts |
| Revenue | N/A | N/A | +4.0% | -2.8% (11yr)1 analysts |
| Net Income | N/A | N/A | +38.0% | -15.1% (11yr)1 analysts |
| EBIT | N/A | N/A | -18.2% | +7.5% (11yr)1 analysts |
Analysis
Recent growth has been strongest in EPS at +40.7% over three years. Forward estimates point to EBIT at +7.5% (11yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Cerus Corporation
NASDAQ:CERS
$512.94M
Canopy Growth Corporation
NASDAQ:CGC
$425.84M
National Research Corporation
NASDAQ:NRC
$423.46M
Viemed Healthcare, Inc.
NASDAQ:VMD
$400.62M
TruBridge, Inc.
NASDAQ:TBRG
$391.78M
SOPHiA GENETICS S.A.
NASDAQ:SOPH
$349.74M
Simulations Plus, Inc.
NASDAQ:SLP
$329.75M
908 Devices Inc.
NASDAQ:MASS
$312.72M
Senseonics Holdings, Inc.
NASDAQ:SENS
$299.93M
Definitive Healthcare Corp.
NASDAQ:DH
$88.59M
Who manages SPOK?
Spok Holdings, Inc. (SPOK) lists 10 active executives. The top listed executive is Vincent D. Kelly, President, Chief Executive Officer & Director.
Are SPOK insiders buying or selling?
Recent insider activity shows net selling of $9.54M.
Explore More
Continue the stock analysis
Jump to another research area for this company.